Abraxis BioScience splits in two
Abraxis BioScience will be separating the company into two independent public companies following accelerated growth, the US-based firm announced this week.
Archives for July 4, 2007
Oxoid's new portable air monitoring device
Microbiology expert Oxoid has released a new active air quality monitoring device to help pharmaceutical companies prove that their clean areas are microbe free.
Novo Nordisk gets transparent on bioethics
Biopharma company Novo Nordisk has launched a new website dedicated to bioethics which it claims is the first of its kind in the industry.
China to play starring role in AstraZeneca API outsourcing
AstraZeneca is planning to gradually withdraw from making its own active pharmaceutical ingredients (APIs) and will use China as the pinnacle of its new outsourcing plans.
Lundbeck needs to buy to avoid deepening crisis
In a refreshingly honest interview with a Danish newspaper, the Lundbeck CEO has admitted his company is in crisis and needs to restock its pipeline to avoid making it any worse.
Quintiles' Indian services biz lays hands on Eli Lilly drug
Quintiles' subsidiary Pharmalink has acquired the marketing rights to Eli Lilly India's flagship antibiotic brand Distaclor (cefaclor) in a bid to boost its core services business.
Needle safety solution wins coveted packaging prize
German packaging firm Gerresheimer has been awarded another prize for its innovative safety-conscious rigid needle shield, this time winning the World Packaging Organisation's renowned WorldStar award.
Drugs moving into the clinic: 21
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
Circassia bags ex GSK chairman
Start-up UK biotech firm Circassia technology has had a major result in bagging 30-year industry veteran and former GlaxoSmithKline (GSK) chairman, Sir Richard Sykes, as its new chairman of the board.
Gel cap strength put to the test
A UK firm has introduced a new piece of kit for pharma firms to test how the contents of their hard gel capsules can affect the strength and stability of the outer shell.